Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asthma ICS down-titration guided by exhaled nitric oxide versus usual clinical care
ACTRN12605000686606Phase 4Completed
- Sponsor
- Cooperative Research Centre for Asthma and Airways
- Start
- Apr 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluticasone, salmeterol and formoterol in asthma (2 arms), sponsored by Cooperative Research Centre for Asthma and Airways. Primary endpoints: Asthma free days and Quality of life. Started Apr 2005; status: completed.
02
Drugs
fluticasonesalmeterolformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12605000686606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000686606.